- Home
- Publications
- Publication Search
- Publication Details
Title
Perspectives of CD44 targeting therapies
Authors
Keywords
CD44, Therapy, Hyaluronan, Receptor tyrosine kinases
Journal
ARCHIVES OF TOXICOLOGY
Volume 89, Issue 1, Pages 3-14
Publisher
Springer Nature
Online
2014-12-04
DOI
10.1007/s00204-014-1424-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD44v6 Dependence of Premetastatic Niche Preparation by Exosomes
- (2015) Thorsten Jung et al. NEOPLASIA
- CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
- (2014) Matilde Todaro et al. Cell Stem Cell
- Antibody Against CD44s Inhibits Pancreatic Tumor Initiation and Postradiation Recurrence in Mice
- (2014) Ling Li et al. GASTROENTEROLOGY
- A Novel CD44-binding Peptide from the Pro-Matrix Metalloproteinase-9 Hemopexin Domain Impairs Adhesion and Migration of Chronic Lymphocytic Leukemia (CLL) Cells
- (2014) Estefanía Ugarte-Berzal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor targeting profiling of hyaluronan-coated lipid based-nanoparticles
- (2014) Shoshy Mizrahy et al. Nanoscale
- DNA Aptamers against Exon v10 of CD44 Inhibit Breast Cancer Cell Migration
- (2014) Joji Iida et al. PLoS One
- MicroRNA-328 Inhibits Renal Tubular Cell Epithelial-to-Mesenchymal Transition by Targeting the CD44 in Pressure-Induced Renal Fibrosis
- (2014) Cheng-Hsien Chen et al. PLoS One
- In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study
- (2014) Anna-Karin Haylock et al. EJNMMI Research
- Self-assembled pH-responsive hyaluronic acid–g-poly(l-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin
- (2013) Lipeng Qiu et al. Acta Biomaterialia
- CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma
- (2013) M. Casucci et al. BLOOD
- Targeted Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in Ovarian Cancer: An Optimal Delivery of siRNA and Anticancer Drug
- (2013) V. Shah et al. CLINICAL CANCER RESEARCH
- CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches
- (2013) Karin Williams et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- MicroRNA-143 Inhibits Migration and Invasion of Human Non-Small-Cell Lung Cancer and Its Relative Mechanism
- (2013) Qingping Ma et al. International Journal of Biological Sciences
- Preclinical evaluation of89Zr-labeled anti-CD44 monoclonal antibody RG7356 in mice and cynomolgus monkeys
- (2013) Danielle J Vugts et al. mAbs
- Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling
- (2013) J Zeilstra et al. ONCOGENE
- Multifunctional Tumor-Targeting Nanocarriers Based on Hyaluronic Acid-Mediated and pH-Sensitive Properties for Efficient Delivery of Docetaxel
- (2013) Shuangshuang Song et al. PHARMACEUTICAL RESEARCH
- Targeting chronic lymphocytic leukemia cells with a humanized monoclonal antibody specific for CD44
- (2013) S. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Opposing effects of high- and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44
- (2013) K Fuchs et al. Cell Death & Disease
- Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist
- (2012) S. Weigand et al. CANCER RESEARCH
- CD44: a validated target for improved delivery of cancer therapeutics
- (2012) Sukhen C Ghosh et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study
- (2012) Michael A. Gold et al. GYNECOLOGIC ONCOLOGY
- A 17-residue Sequence from the Matrix Metalloproteinase-9 (MMP-9) Hemopexin Domain Binds α4β1 Integrin and Inhibits MMP-9-induced Functions in Chronic Lymphocytic Leukemia B Cells
- (2012) Estefanía Ugarte-Berzal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Near-Infrared Fluorescence Molecular Imaging of Ductal Carcinoma In Situ with CD44v6-Specific Antibodies in Mice: A Preclinical Study
- (2012) Jeroen F. Vermeulen et al. MOLECULAR IMAGING AND BIOLOGY
- Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion
- (2012) Laisheng Li et al. MOLECULAR THERAPY
- CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc− and Thereby Promotes Tumor Growth
- (2011) Takatsugu Ishimoto et al. CANCER CELL
- FKBPL and Peptide Derivatives: Novel Biological Agents That Inhibit Angiogenesis by a CD44-Dependent Mechanism
- (2011) A. Valentine et al. CLINICAL CANCER RESEARCH
- Hyaluronic acid-based nanocarriers for intracellular targeting: Interfacial interactions with proteins in cancer
- (2011) Ki Young Choi et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Hyaluronan-CD44 interactions as potential targets for cancer therapy
- (2011) Suniti Misra et al. FEBS Journal
- c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target
- (2011) Chenwei Li et al. GASTROENTEROLOGY
- Head neck squamous cell carcinoma c-Met+ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis
- (2011) Shuyang Sun et al. INTERNATIONAL JOURNAL OF CANCER
- CD44v6 Coordinates Tumor Matrix-triggered Motility and Apoptosis Resistance
- (2011) Thorsten Jung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A6 Peptide Activates CD44 Adhesive Activity, Induces FAK and MEK Phosphorylation, and Inhibits the Migration and Metastasis of CD44-Expressing Cells
- (2011) R. S. Piotrowicz et al. MOLECULAR CANCER THERAPEUTICS
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
- (2011) Can Liu et al. NATURE MEDICINE
- miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell lines
- (2010) Jon C. Henry et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CD44, a therapeutic target for metastasising tumours
- (2010) Véronique Orian-Rousseau EUROPEAN JOURNAL OF CANCER
- A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis
- (2009) M. Tremmel et al. BLOOD
- MicroRNAs and Cancer: Short RNAs Go a Long Way
- (2009) Andrea Ventura et al. CELL
- The miR-34 family in cancer and apoptosis
- (2009) H Hermeking CELL DEATH AND DIFFERENTIATION
- Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell
- (2009) G. Sotiropoulou et al. RNA
- Cancer stem cells: markers or biomarkers?
- (2008) Wendy A. Woodward et al. CANCER AND METASTASIS REVIEWS
- Deletion of the WNT Target and Cancer Stem Cell Marker CD44 in Apc(Min/+) Mice Attenuates Intestinal Tumorigenesis
- (2008) J. Zeilstra et al. CANCER RESEARCH
- A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous Å6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer
- (2008) Sharad A. Ghamande et al. GYNECOLOGIC ONCOLOGY
- Preparation and characterization of HA–PEG–PCL intelligent core–corona nanoparticles for delivery of doxorubicin
- (2008) Awesh Kumar Yadav et al. JOURNAL OF DRUG TARGETING
- Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma
- (2008) Herbert Riechelmann et al. ORAL ONCOLOGY
- Targeting CD44v6 Expressed in Head and Neck Squamous Cell Carcinoma: Preclinical Characterization of an 111In-Labeled Monoclonal Antibody
- (2008) Karl Sandström et al. TUMOR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation